Alsoufi Bahaaldin, Al-Radi Osman O, Gruenwald Colleen, Lean Lynn, Williams William G, McCrindle Brian W, Caldarone Christopher A, Van Arsdell Glen S
King Faisal Heart Institute, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Eur J Cardiothorac Surg. 2009 Jun;35(6):1004-11; discussion 1011. doi: 10.1016/j.ejcts.2009.02.015. Epub 2009 Apr 7.
Application of extra-corporeal life support (ECLS) following pediatric cardiac surgery varies between different institutions based on manpower availability and philosophy towards ECLS utilization. We examined a large single institution experience with postoperative ECLS in children aiming to identify outcome predictors.
Hospital records of all children who required postoperative ECLS at our institution were reviewed. Patients' demographics, cardiac anatomy, surgical and ECLS support details were entered into a multivariable regression analysis to determine factors associated with survival.
Between 1990 and 2007, 180 consecutive children, median age 109 days (range: 1 day-16.9 years), required postoperative ECLS. Sixty-nine children (38%) had undergone palliative treatment for single ventricle pathology. ECLS support was required for failure to separate from cardiopulmonary bypass (n=83) or for postoperative low cardiac output state (n=97). Forty-eight patients (27%) received rescue extra-corporeal membrane oxygenation (ECMO) support during active chest compression for refractory cardiac arrest. Under ECLS support, 37 patients required surgical revision and 20 received orthotopic heart transplantation. One hundred and nine patients (61%) survived >24h following ECLS discontinuation and 68 (38%) were discharged alive. Hospital survivors required shorter ECLS support duration compared to non-survivors (median 3 vs 5 days, respectively, p=0.05) however survival occurred after up to 16 days of ECLS support. ECLS indication (OR: 0.85 for failure to separate from bypass vs postoperative low cardiac output 95% CI (0.47-1.56), p=0.62) and rescue ECMO (OR: 0.63 for rescue ECMO vs not 95%CI (0.32-1.24), p=0.18) were not associated with risk of mortality. In a multivariable logistic regression model, neurological complications (p=0.0007), prolonged ECLS duration (p=0.003), repeat ECLS requirement (p=0.02), renal dysfunction (p=0.04) and not performing heart transplantation (p=0.04) were significant factors for hospital death.
ECLS plays a valuable role in children with low cardiac output state following cardiac surgery. More than one third of those patients, including young neonates, older children, patients with single ventricle, or those requiring rescue ECMO can be salvaged. Although prognosis worsens with prolonged ECLS duration, survival can be noted up to 16 days of support. Heart transplantation is often an important ECLS exit strategy and should be considered early in selected children. Patients' survival could improve if renal and neurological complications are avoided.
小儿心脏手术后体外生命支持(ECLS)的应用在不同机构间存在差异,这取决于人力可用性和对ECLS使用的理念。我们研究了一家大型单一机构中儿童术后ECLS的大量经验,旨在确定预后预测因素。
回顾了我们机构所有需要术后ECLS的儿童的医院记录。将患者的人口统计学、心脏解剖结构、手术和ECLS支持细节纳入多变量回归分析,以确定与生存相关的因素。
1990年至2007年期间,连续180名儿童,中位年龄109天(范围:1天至16.9岁),需要术后ECLS。69名儿童(38%)因单心室病变接受了姑息治疗。因体外循环无法脱离(n = 83)或术后低心排血量状态(n = 97)需要ECLS支持。48名患者(27%)在积极胸外按压治疗难治性心脏骤停期间接受了挽救性体外膜肺氧合(ECMO)支持。在ECLS支持下,37名患者需要手术修正,20名接受了原位心脏移植。109名患者(61%)在ECLS停止后存活超过24小时,68名(38%)存活出院。与未存活者相比,医院存活者需要的ECLS支持时间更短(中位时间分别为3天和5天,p = 0.05),然而在长达16天的ECLS支持后仍有存活者。ECLS指征(体外循环无法脱离与术后低心排血量相比的比值比:0.85,95%可信区间(0.47 - 1.56),p = 0.62)和挽救性ECMO(挽救性ECMO与未接受相比的比值比:0.63,95%可信区间(0.32 - 1.24),p = 0.18)与死亡风险无关。在多变量逻辑回归模型中,神经并发症(p = 0.0007)、延长的ECLS持续时间(p = 0.003)、再次需要ECLS(p = 0.02)、肾功能不全(p = 0.04)和未进行心脏移植(p = 0.04)是医院死亡的重要因素。
ECLS在心脏手术后低心排血量状态的儿童中发挥着重要作用。超过三分之一的此类患者,包括新生儿、大龄儿童、单心室患者或需要挽救性ECMO的患者可以获救。尽管随着ECLS持续时间延长预后恶化,但在长达16天的支持后仍可观察到存活者。心脏移植通常是重要的ECLS撤离策略,应在选定的儿童中尽早考虑。如果避免肾和神经并发症,患者的存活率可能会提高。